Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review

Masato Ishida, Yuki Kuroiwa, Emiko Yoshida, Masayo Sato, Dominika Krupa, Nathaniel Henry, Kei Ikeda, Yuko Kaneko

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: To identify, describe and summarize evidence on residual symptoms and disease burdens in rheumatoid arthritis (RA) patients qualified as being in remission or low disease activity (LDA). Methods: A systematic literature review (SLR) was conducted according to Cochrane collaboration guidelines. The population of interest was adult patients with RA in remission or LDA. The reported outcomes of interest were any symptoms or burdens. Results: Fifty-one publications were identified through an eDatabase search. Together with 17 articles found through other sources, 68 were included for full text review. The most commonly reported residual symptoms were pain (number of studies = 25), fatigue (n = 21) and morning stiffness (n = 5). Reported disease burdens included mental health (n = 15), sleep disturbances (n = 7) and work productivity (n = 5), impairment in quality of life (n = 21), and functional disability (n = 34). Substantial residual symptoms and disease burdens were found to be present in patients in remission or LDA. Conclusion: This is the first SLR to investigate residual symptoms and disease burdens in RA patients in remission or LDA. The results indicate that despite achieving conventional clinical targets, the disease continues to affect patients, suggesting the existence of unmet need under the current treatment paradigm.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalModern Rheumatology
DOIs
Publication statusAccepted/In press - 2018 Jan 11

Fingerprint

Rheumatoid Arthritis
Fatigue
Publications
Mental Health
Sleep
Quality of Life
Guidelines
Pain
Population

Keywords

  • Low disease activity
  • remission
  • residual symptom
  • rheumatoid arthritis
  • systematic literature review

ASJC Scopus subject areas

  • Rheumatology

Cite this

Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity : a systematic literature review. / Ishida, Masato; Kuroiwa, Yuki; Yoshida, Emiko; Sato, Masayo; Krupa, Dominika; Henry, Nathaniel; Ikeda, Kei; Kaneko, Yuko.

In: Modern Rheumatology, 11.01.2018, p. 1-11.

Research output: Contribution to journalArticle

Ishida, Masato ; Kuroiwa, Yuki ; Yoshida, Emiko ; Sato, Masayo ; Krupa, Dominika ; Henry, Nathaniel ; Ikeda, Kei ; Kaneko, Yuko. / Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity : a systematic literature review. In: Modern Rheumatology. 2018 ; pp. 1-11.
@article{62124ffb236f4babbf29c550f4899cb4,
title = "Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review",
abstract = "Objectives: To identify, describe and summarize evidence on residual symptoms and disease burdens in rheumatoid arthritis (RA) patients qualified as being in remission or low disease activity (LDA). Methods: A systematic literature review (SLR) was conducted according to Cochrane collaboration guidelines. The population of interest was adult patients with RA in remission or LDA. The reported outcomes of interest were any symptoms or burdens. Results: Fifty-one publications were identified through an eDatabase search. Together with 17 articles found through other sources, 68 were included for full text review. The most commonly reported residual symptoms were pain (number of studies = 25), fatigue (n = 21) and morning stiffness (n = 5). Reported disease burdens included mental health (n = 15), sleep disturbances (n = 7) and work productivity (n = 5), impairment in quality of life (n = 21), and functional disability (n = 34). Substantial residual symptoms and disease burdens were found to be present in patients in remission or LDA. Conclusion: This is the first SLR to investigate residual symptoms and disease burdens in RA patients in remission or LDA. The results indicate that despite achieving conventional clinical targets, the disease continues to affect patients, suggesting the existence of unmet need under the current treatment paradigm.",
keywords = "Low disease activity, remission, residual symptom, rheumatoid arthritis, systematic literature review",
author = "Masato Ishida and Yuki Kuroiwa and Emiko Yoshida and Masayo Sato and Dominika Krupa and Nathaniel Henry and Kei Ikeda and Yuko Kaneko",
year = "2018",
month = "1",
day = "11",
doi = "10.1080/14397595.2017.1416940",
language = "English",
pages = "1--11",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity

T2 - a systematic literature review

AU - Ishida, Masato

AU - Kuroiwa, Yuki

AU - Yoshida, Emiko

AU - Sato, Masayo

AU - Krupa, Dominika

AU - Henry, Nathaniel

AU - Ikeda, Kei

AU - Kaneko, Yuko

PY - 2018/1/11

Y1 - 2018/1/11

N2 - Objectives: To identify, describe and summarize evidence on residual symptoms and disease burdens in rheumatoid arthritis (RA) patients qualified as being in remission or low disease activity (LDA). Methods: A systematic literature review (SLR) was conducted according to Cochrane collaboration guidelines. The population of interest was adult patients with RA in remission or LDA. The reported outcomes of interest were any symptoms or burdens. Results: Fifty-one publications were identified through an eDatabase search. Together with 17 articles found through other sources, 68 were included for full text review. The most commonly reported residual symptoms were pain (number of studies = 25), fatigue (n = 21) and morning stiffness (n = 5). Reported disease burdens included mental health (n = 15), sleep disturbances (n = 7) and work productivity (n = 5), impairment in quality of life (n = 21), and functional disability (n = 34). Substantial residual symptoms and disease burdens were found to be present in patients in remission or LDA. Conclusion: This is the first SLR to investigate residual symptoms and disease burdens in RA patients in remission or LDA. The results indicate that despite achieving conventional clinical targets, the disease continues to affect patients, suggesting the existence of unmet need under the current treatment paradigm.

AB - Objectives: To identify, describe and summarize evidence on residual symptoms and disease burdens in rheumatoid arthritis (RA) patients qualified as being in remission or low disease activity (LDA). Methods: A systematic literature review (SLR) was conducted according to Cochrane collaboration guidelines. The population of interest was adult patients with RA in remission or LDA. The reported outcomes of interest were any symptoms or burdens. Results: Fifty-one publications were identified through an eDatabase search. Together with 17 articles found through other sources, 68 were included for full text review. The most commonly reported residual symptoms were pain (number of studies = 25), fatigue (n = 21) and morning stiffness (n = 5). Reported disease burdens included mental health (n = 15), sleep disturbances (n = 7) and work productivity (n = 5), impairment in quality of life (n = 21), and functional disability (n = 34). Substantial residual symptoms and disease burdens were found to be present in patients in remission or LDA. Conclusion: This is the first SLR to investigate residual symptoms and disease burdens in RA patients in remission or LDA. The results indicate that despite achieving conventional clinical targets, the disease continues to affect patients, suggesting the existence of unmet need under the current treatment paradigm.

KW - Low disease activity

KW - remission

KW - residual symptom

KW - rheumatoid arthritis

KW - systematic literature review

UR - http://www.scopus.com/inward/record.url?scp=85041120419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041120419&partnerID=8YFLogxK

U2 - 10.1080/14397595.2017.1416940

DO - 10.1080/14397595.2017.1416940

M3 - Article

C2 - 29251034

AN - SCOPUS:85041120419

SP - 1

EP - 11

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

ER -